AZ, Dentsply close to deal on Astra Tech

AstraZeneca is reportedly close to an agreement for selling its dental implant and medical device unit Astra Tech to Dentsply International for approximately $1.8 billion, said a person close to the deal. However, no deal has been reached and the talks may still fall apart, Bloomberg quotes the source as saying. News

Suggested Articles

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.